70: HealthTech Hour with Steve Roest - Episode 70

70: HealthTech Hour with Steve Roest - Episode 70

How do individuals turn their lives around after addiction? This week's HealthTech Hour with Steve Roest offers a fascinating look into the cutting-edge world of pharmacogenomics and its potential to revolutionise healthcare. Dr. Mark Hudson-Peacock, founder and CEO of Mantara, joins the conversation to discuss how genetic testing can tailor medication to individual needs, potentially reducing side effects and increasing efficacy.

With pharmacogenomics being a hot topic in healthcare innovation, this episode sheds light on its current status and future prospects. Dr. Hudson-Peacock explains how pharmacogenomic testing can personalise treatments, particularly for mental health and cardiovascular conditions, offering hope for more effective healthcare solutions. The discussion isn't just about the science; it's also about the practicalities of implementing such technology within existing healthcare systems.

From the challenges of gaining acceptance among medical professionals to the logistical hurdles of widespread adoption, you'll gain a comprehensive understanding of where we stand today. The episode also touches on the broader implications for the pharmaceutical industry, suggesting a future where drugs are designed with genetic profiles in mind. For those interested in the intersection of technology and healthcare, this episode provides a window into the transformative potential of pharmacogenomics.

It's an engaging listen that combines expert insights with real-world applications, making complex topics accessible and intriguing. Are we on the brink of a healthcare revolution? Tune in to find out.